No Data
No Data
Aier Eye Hospital Group Co., Ltd.'s (SZSE:300015) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Aier Eye Hospital Group (SZSE:300015) has had a rough three months with its share price down 12%. However, a closer look at its sound financials might cause you to think again. Given that
Morgan Stanley Downgrades Aier Eye Hospital to Underweight From Equal-weight; Price Target Is 9.80 Yuan
Aier Eye Hospital (SHE:300015) has an average rating of outperform and price targets ranging from 9.80 yuan to 24.60 yuan, according to analysts polled by CapitalIQ. Price (RMB): ¥9.88, Change: ¥-0.40
Aier Eye Hospital Group (300015.SZ) has repurchased a total of 12.6587 million shares, with a total cost of 218 million yuan.
Aier Eye Hospital Group (300015.SZ) announced that as of June 30, 2024, the company repurchased 12.6587 million shares of the company through centralized bidding trading, accounting for 0.14% of the total share capital of the company. The total transaction amount was 218 million yuan (excluding transaction fees).
Private Companies Among Aier Eye Hospital Group Co., Ltd.'s (SZSE:300015) Largest Stockholders and Were Hit After Last Week's 3.9% Price Drop
Key Insights Aier Eye Hospital Group's significant private companies ownership suggests that the key decisions are influenced by shareholders from the larger public The top 3 shareholders own 53% of
List of unrestricted A-share shares of Zhitong | June 17.
On June 17th, a total of 32 listed companies had restricted stocks lifted, with a total market value of approximately 35.571 billion yuan. The specific situation of restricted stock lifting is as follows: Stock Code Stock Name Type of Restricted Shares Number of Lifting Shares Xiamen C&D Inc. 600153 Stock-based Incentive Restricted Circulation 9.5414 million Haohua Chemical Science & Technology Corp. 600378 Stock-based Incentive Restricted Circulation 6.8733 million ENN Natural Gas 600803 Stock-based Incentive Restricted Circulation 4.2525 million IDT Corp 002308 Stock-based Incentive Restricted Circulation 4.8495 million Aier Eye Hospital Group 300015 Stock-based Incentive Restricted Circulation 20.015 million
Using crowd actors for false advertising? Aier Eye Hospital Group responded: malicious slander will be held accountable.
On the afternoon of June 14th, Beijing Aier Yingzhi Eye Hospital's official Weibo account issued a statement regarding the media report on the 'man who regained his sight after a corneal transplant after being blind for 12 years'. The statement said that recently, the media reported once again the story of the man who regained his sight after a corneal transplant after being blind for 12 years, and some netizens posted maliciously discrediting information, such as 'false propaganda repeatedly performed by civilian actors'. Hereby, the hospital solemnly declares that the patient's diagnosis and treatment process and results are all true, and the news media has reported on it many times. The hospital has actively cooperated to respond to the call of China's Organ Donation Day, and promote positive social energy.
No Data